Home > Insider Trading > Filing (0001209191-13-045956)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1385228	Bind Therapeutics Inc	BIND	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1255927	Jr M Edwin Kania	1 Memorial Drive, 7Th Floor Cambridge MA 02142	No	No	Yes	No
1299790	P L 2004 Fund Ventures Flagship	1 Memorial Drive, 7Th Floor Cambridge MA 02142	No	No	Yes	No
1400249	Flagship Ventures General Partner Llc	1 Memorial Drive, 7Th Floor Cambridge MA 02142	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-09-25	1,542,616	$0.00	1,542,616	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2013-09-25	20,000	$15.00	1,562,616	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See footnote
No	4	P	Indirect	See footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2013-09-25	984,640	$0.00	375,816	$0.00
Common Stock	Series B Preferred Stock	Disposition	2013-09-25	1,900,000	$0.00	725,190	$0.00
Common Stock	Series C Preferred Stock	Disposition	2013-09-25	416,667	$0.00	159,033	$0.00
Common Stock	Series C-1 Preferred Stock	Disposition	2013-09-25	333,288	$0.00	127,209	$0.00
Common Stock	Series D Preferred Stock	Disposition	2013-09-25	407,060	$0.00	155,366	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

The convertible preferred stock is convertible at any time, at the holder's election, and has no expiration date. Immediately prior to closing of the issuer's initial public offering, the preferred stock held by the reporting person automatically converted into common stock on a 2.62 to 1 basis.
Held by Flagship Ventures Fund 2004, L.P. ("Flagship 2004"). Flagship Ventures General Partner LLC ("Flagship LLC") is the general partner of Flagship 2004. Noubar B. Afeyan Ph.D. and Edwin M. Kania, Jr. are the managers of Flagship LLC. Flagship LLC and each of these individuals may be deemed to share voting and investment power with respect to all shares held by Flagship 2004. Each of the reporting persons disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein. Dr. Afeyan, a director of the issuer, is filing a separate Form 4.